切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (05) : 295 -299. doi: 10.3877/cma.j.issn.1674-0807.2016.05.009

论著

超声和X 线检查对乳腺病变的诊断效能分析
李毅1,(), 吕艳丽1, 赵越1, 秦红风1, 赵艳君1, 许伶俐1, 殷艳宇1, 杨春霞1   
  1. 1.101300 北京市顺义区妇幼保健院乳腺中心
  • 收稿日期:2016-04-26 出版日期:2016-10-01
  • 通信作者: 李毅

Diagnostic efficacy analysis of ultrasonography and mammography for breast lesions

Yi Li1,(), Yanli Lyu1, Yue Zhao1, Hongfeng Qin1, Yanjun Zhao1, Linli Xu1, Yanyu Yin1, Chunxia Yang1   

  1. 1.Breast Disease Center, Shunyi Health Care Hospital for Women and Children, Beijing 101300, China
  • Received:2016-04-26 Published:2016-10-01
  • Corresponding author: Yi Li
引用本文:

李毅, 吕艳丽, 赵越, 秦红风, 赵艳君, 许伶俐, 殷艳宇, 杨春霞. 超声和X 线检查对乳腺病变的诊断效能分析[J/OL]. 中华乳腺病杂志(电子版), 2016, 10(05): 295-299.

Yi Li, Yanli Lyu, Yue Zhao, Hongfeng Qin, Yanjun Zhao, Linli Xu, Yanyu Yin, Chunxia Yang. Diagnostic efficacy analysis of ultrasonography and mammography for breast lesions[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2016, 10(05): 295-299.

目的

探讨超声和X 线检查对乳腺病变的诊断效能。

方法

回顾性分析2007—2014 年在北京市顺义区妇幼保健院乳腺中心就诊的1 083 例患者乳腺病变的超声和X 线影像诊断资料。 根据年龄将患者分为<40 岁、40 ~49 岁、50 ~59 岁和≥60 岁4 个组,根据腺体密度将患者分为Ⅰ~Ⅳ度4 个组。 以病理诊断为金标准,超声和X 线BI-RADS 分级4 ~5 级为阳性结果,采用受试者工作特征(ROC)曲线对两者诊断效能进行评价。 采用Kappa 检验评价超声和X 线检查单独及联合使用的一致性。

结果

1 083 例患者均有明确病理诊断,包括乳腺癌386 例和良性疾病697 例。 在386 例乳腺癌患者中,超声单独诊断乳腺癌的敏感度和特异度分别为93.0%(359/386)和87.8%(612/697),X 线单独诊断乳腺癌的敏感度和特异度分别为76.2%(294/386)和92.4%(644/697),两者联合诊断乳腺癌的敏感度和特异度分别为95.1%(367/386)和82.6%(576/697)。 以病理诊断为金标准,超声和X 线检查与金标准的一致性检验Kappa 值分别为0.782 和0.701,联合诊断的Kappa 值为0.734(P 均<0.001)。 乳腺超声和X 线诊断的ROC 曲线下面积分别为0.904(95%CI:0.885 ~0.921,P<0.001)和0.843(95%CI:0.820 ~0.864,P<0.001),超声的诊断价值优于X 线(Z=5.930, P<0.001)。 对于4 个年龄组研究对象,超声的诊断价值均优于X 线(Z=2.549、5.332、3.584 和2.031, P 均<0.050)。 超声和X 线对于乳腺腺体分型为Ⅱ度者诊断价值相当(Z=0.178,P=0.859),而超声对腺体分型为Ⅰ度、Ⅲ度和Ⅳ度者的诊断价值均高于X 线(Z=2.129、5.847、3.437,P 均<0.050)。

结论

超声和X 线对乳腺病变均有较好的诊断价值,超声的诊断价值略优于X 线。 建议临床实践中对于致密型乳腺,在X 线检查的基础上结合超声检查,以提高乳腺病变检出率。

Objective

To investigate the diagnostic performance of ultrasonography (US) and mammography (MAM) for breast lesions.

Methods

The US and MAM imaging data of 1 083 patients with breast diseases in Shunyi Health Care Hospital for Women and Children in 2007-2014 were retrospectively analyzed. The patients were divided into 4 groups: <40 years,40-49 years,50-59 years, ≥60 years, or the patients were divided into 4 groups of Ⅰ-Ⅳbased on breast density. Pathological diagnosis of the lesions was set as the gold standard, and the BI-RADS grades 4 and 5 of US and MAM were regarded as positive results.ROC curve analysis was used to evaluate the diagnosis performances of US and MAM. Kappa test was used to evaluate the consistency of US, MAM and combined diagnosis of both.

Results

All patients had definite pathological diagnosis, including 386 cases of breast cancer and 697 cases of benign diseases. Among 386 cases of breast cancer, the sensitivity and specificity of US alone for diagnosis of breast cancer were 93.0%(359/386) and 87.8% (612/697), and the sensitivity and specificity of MAM alone were 76.2%(294/386) and 92.4% (644/697), and the sensitivity and specificity of combined diagnosis were 95.1%(367/386) and 82.6% (576/697). With pathological diagnosis as the gold standard, the Kappa values of US and MAM in consistency test were 0.782 and 0.701 respectively, and the Kappa value of combined diagnosis was 0.734 (all P<0.001). The areas under ROC curves of US and MAM for diagnosis of breast lesions were 0.904 (95%CI:0.885-0.921, P<0.001) and 0.843 (95%CI: 0.820-0.864, P<0.001), respectively.US was significantly superior to MAM (Z=5.930,P<0.001). In 4 age groups, US had a better diagnostic value compared with MAM (Z = 2.549, 5.332, 3.584, 2.031, all P<0.050). US and MAM had an equivalent diagnostic value for lesions of grade Ⅱbreast density (Z=0.178, P=0.859), while US had an significantly better diagnostic value for lesions of gradesⅠ, Ⅲand Ⅳbreast density (Z=2.129, 5.847,3.437, all P<0.050).

Conclusions

Both US and MAM show a good diagnostic value for breast lesions,while US is more effective than MAM. MAM combined with US is recommended for women with dense breast in clinical practice, in order to improve the detection rate of breast lesions.

表1 乳腺超声和X 线检查单独及联合诊断结果(例)
图1 不同年龄组乳腺疾病患者超声和X 线诊断的ROC 曲线 注:a ~d 图分别代表<40 岁、40 ~49 岁、50 ~59 岁和≥60 岁年龄组患者超声和X 线诊断的ROC 曲线。 ROC 表示受试者工作特征曲线;AUC 表示ROC 曲线下面积;a 图的超声诊断AUC 为0.916,95%CI:0.853 ~0.958,P<0.001,a 图的X 线诊断AUC 为0.796,95%CI:0.715 ~0.862,P<0.001;b 图的超声诊断AUC 为0.880,95%CI:0.848 ~0.907,P<0.001,b 图的X 线诊断AUC 为0.771,95%CI:0.732 ~0.807,P<0.001;c 图的超声诊断AUC 为0.909,95%CI:0.872 ~0.938,P<0.001,c 图的X线诊断AUC 为0.853,95%CI:0.809 ~0.890,P<0.001;d 图的超声诊断AUC 为0.896,95%CI:0.832 ~0.942,P<0.001,d 图的X 线诊断AUC 为0.877,95%CI:0.808 ~0.927,P<0.001;4 个组中超声诊断价值均优于X 线,Z=2.549、5.332、3.584、2.031,P 均<0.050
图2 不同腺体密度组乳腺疾病患者超声和X 线诊断的ROC 曲线 注:a ~d 图分别代表脂肪型Ⅰ度、少量腺体型Ⅱ度、多量腺体型Ⅲ度和致密型组Ⅳ度患者超声和X 线诊断的ROC 曲线。ROC 表示受试者工作特征曲线;AUC 表示ROC 曲线下面积;a 图的超声诊断AUC 为0.907,95%CI:0.817 ~0.962,P<0.001,a 图的X 线诊断AUC 为0.847,95%CI:0.745 ~0.920,P<0.001;b 图的超声诊断AUC 为0.907,95%CI:0.857 ~0.944,P<0.001,b 图的X 线诊断AUC 为0.904,95%CI:0.854 ~0.942,P<0.001;c 图的超声诊断AUC 为0.895,95%CI:0.870 ~0.916,P<0.001,c 图的X 线诊断AUC 为0.807,95%CI:0.776 ~0.835,P<0.001;d 图的超声诊断AUC 为0.943,95%CI:0.870 ~0.982,P<0.001,d 图的X 线诊断AUC 为0.700,95%CI:0.590 ~0.795,P=0.004;腺体分型为Ⅱ度者超声和X 线诊断价值相当,差异无统计学意义,Z=0.178,P=0.859,而腺体分型为Ⅰ度、Ⅲ度和Ⅳ度者超声的诊断价值均优于X 线,Z=2.129、5.847、3.437,P 均<0.050
[1]
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2013 版)[J]. 中国癌症杂志,2013,23(8):637-684.
[2]
American College of Radiology. Illustrated Breast Imaging Reporting and Data System (BI-RADS). [EB/OL]. [2016-04-20]. www. acr.org/Quality—Satety/Resources/BIRADS.
[3]
Li J, Xing P, Feng L, et al. The value of substratified imaging assessment with mammography and ultrasonography for Chinese women with palpable breast masses[J]. Breast Cancer Res Treat, 2014,144(2):391-396.
[4]
Zhao H, Zou L, Geng X, et al. Limitations of mammography in the diagnosis of breast diseases compared with ultrasonography: a singlecenter retrospective analysis of 274 cases[J]. Eur J Med Res,2015,20:49.
[5]
谢娟,吴蓉,徐辉雄,等.超声与X 线摄影对乳腺病变诊断价值的研究[J/CD].中华临床医师杂志:电子版,2013,7(17):7838-7842.
[6]
U.S Preventive Services Task Force. Screening for breast cancer:U.S.Preventive Services Task Force recommendation statement[J]. Ann Intern Med,2009,151(10):716-726.
[7]
Perry N, Broeders M, Wolf C,et al. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document[J]. Ann Oncol,2008,19(4):614-622.
[8]
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Breast-cancer screening --viewpoint of the IARC Working Group[J]. N Engl J Med,2015,372(24):2353-2358.
[9]
Bae MS, Moon WK, Chang JM, et al. Breast cancer detected with screening US: reasons for nondetection at mammography [ J].Radiology,2014,270(2):369-377.
[10]
Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer[J]. JAMA,2008,299(18):2151-2163.
[11]
Corsetti V, Houssami N, Ghirardi M, et al. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts:interval breast cancers at 1 year follow-up[J]. Eur J Cancer,2011,47(7):1021-1026.
[12]
Ohuchi N, Suzuki A, Sobue T,et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (JSTART): a randomised controlled trial[J]. Lancet, 2016,387(10 016):341-348.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[3] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[4] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[5] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[6] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[7] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[8] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[9] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[10] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[11] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[12] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要